
Karlin Pharmaceuticals & Exports Private Limited
Manufactures and exports pharmaceutical products, including medicines, compounds, and medical equipment.
Manufactures and exports pharmaceutical products, including medicines, compounds, and medical equipment.
Karlin Pharmaceuticals & Exports Private Limited (KPEPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 March 1999 and has a history of 25 years and 11 months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.47 Cr. The company has closed loans amounting to ₹8.73 M, as per Ministry of Corporate Affairs (MCA) records.
Budruddin Ahamed and Ameenuddinb serve as directors at the Company.
Tiruvallur, Tamil Nadu, India
+91-XXXXXXXXXX
-
U24231TN1999PTC042105
042105
Private Limited Indian Non-Government Company
22 Mar 1999
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chennai
Karlin Pharmaceuticals & Exports Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Ointment.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Budruddin Ahamed ![]() | Director | 22-Mar-1999 | Current |
Ameenuddinb ![]() | Director | 14-Mar-2018 | Current |
Karlin Pharmaceuticals & Exports Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.59% increase. The company also saw a slight decrease in profitability, with a 7.49% decrease in profit. The company's net worth dipped by a decrease of 1.51%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Karlin Pharmaceuticals & Exports had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹14.67 M
₹8.73 M
Date | Lender | Amount | Status |
---|---|---|---|
03 Sep 2022 | Canara Bank | ₹1.45 M | Open |
03 Sep 2022 | Canara Bank | ₹0.72 M | Open |
25 Apr 2019 | Canara Bank | ₹1.25 Cr | Open |
01 Jun 2015 | Canara Bank | ₹5.73 M | Satisfied |
18 May 2006 | Canara Bank | ₹3.00 M | Satisfied |
Unlock and access historical data on people associated with Karlin Pharmaceuticals & Exports, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Karlin Pharmaceuticals & Exports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karlin Pharmaceuticals & Exports's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Canara Bank of Rs. 12.50 M registered on 25 Apr 2019 with Charge ID 100268187 was modified on 09 Oct 2023.
09 Oct 2023
Karlin Pharmaceuticals & Exports Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023
Karlin Pharmaceuticals & Exports Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
31 Mar 2023
A charge with Canara Bank amounted to Rs. 1.45 M with Charge ID 100657026 was registered on 03 Sep 2022.
03 Sep 2022
A charge with Canara Bank amounted to Rs. 0.72 M with Charge ID 100657027 was registered on 03 Sep 2022.
03 Sep 2022
A charge with Canara Bank amounted to Rs. 12.50 M with Charge ID 100268187 was registered on 25 Apr 2019.
25 Apr 2019
Karlin Pharmaceuticals & Exports Private Limited was incorporated on 22 Mar 1999.
The authorized share capital of Karlin Pharmaceuticals & Exports Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Karlin Pharmaceuticals & Exports Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Karlin Pharmaceuticals & Exports Private Limited is No.140, Indira Nagarvalasaravakkam India, Chennai - 87., Tamil Nadu, 600087.
The corporate identification number (CIN) of Karlin Pharmaceuticals & Exports Private Limited is U24231TN1999PTC042105 and the company number is 042105 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Karlin Pharmaceuticals & Exports Private Limited has risen by 4.59%.
The financial reports for the fiscal year 2022 indicates that The net worth of Karlin Pharmaceuticals & Exports Private Limited has experienced an downturn of -1.51%.
As per the financial statements for fiscal Year 2022, The total open charges for Karlin Pharmaceuticals & Exports Private Limited amount to ₹ 1.47 Cr.
The most recent Balance Sheet for Karlin Pharmaceuticals & Exports Private Limited was filed with the ROC on 31 Mar 2023.